DUBLIN–(BUSINESS WIRE)–The “Single-use Bioreactors Market Size, Share & Trends Analysis Report by Product, by Type, by Type Of Cell, by Molecule Type, by Application, by End-use, by Usage Type, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.
The global single-use bioreactors market size is expected to reach USD 12,062.5 million by 2030. The market is expected to expand at a CAGR of 17.6% from 2022 to 2030. Owing to the rising demand for biopharmaceuticals, coupled with increasing investments in single-use technologies, the market for single-use bioreactors is expected to witness a significant growth throughout the forecast period.
The value of the product, the time required for product development and production, and the criticality of the phase are now influencing the industry’s propensity to employ single-use bioreactors. In addition, the medical industry has a significant demand for these single-use bioreactors. As a result, pharmaceutical companies use these reactors to make medicines without having to compromise on their quality. The flexibility of using single-use bioreactors is one of their main benefits. The growing trend toward multi-drug facilities necessitates the manufacture of various medications utilizing the same facility, in the shortest amount of time, and for the least amount of money. Thus, it will increase the demand for single-use bioreactors and further fuels market growth.
Additionally, the market for single-use bioreactors is anticipated to increase quickly because of considerable prospects from emerging countries, the demand for customized medicine, and an anticipated rise in biosimilar production in the U.S. For instance, around $110 billion worth of biologics is anticipated to lose their patent protection by 2020. The demand for biosimilar is therefore expected to rise in the upcoming years as a result of mounting pressure to lower healthcare costs and regulatory certainty about biosimilar and further driving the market growth.
However, the administration of single-use bioreactors-related challenges and worries about leachable and extractable are most likely to impede the market’s expansion over the anticipated time. Additionally, the single-use bioreactors market is projected to benefit from new opportunities brought on by license termination and emerging markets. Despite this, the market is primarily being driven by growing SUB usage among startups and small businesses, technological developments in SUB, and the benefits offered by these products.
Additionally, SUBs have been used more frequently lately in contemporary biopharmaceutical operations. This is mainly because of its exceptional capacity to increase flexibility, decrease investment, and regulate operational expenses. Furthermore, single-use bioreactors have a wide range of uses in academic and industrial laboratories, including drug discovery, pharmaceutical, environmental, and life science research for the production of vaccines, antibodies, cell culture, and biofuels, among other things. Thus, it will increase the demand and further boost the market growth.
Single-use Bioreactors Market Report Highlights
- By product, the single use bioreactor systemssegment held the larger share in 2021. The availability of disposable bioprocess bags in different sizes for a variety of uses, including the storage of reagents, buffers, sterile medium, sera, and cell cultures, is predicted to drive the market’s expansion
- By type, the stirred tank bioreactors segment held a larger share in 2021, driven by the increasing adoption of stirred tank SUBs from pilot scale to large scale manufacturing is anticipated to boost the market growth in the forecast years
- Based on type of cell, the mammalian cells segment held a larger share in 2021. The segment is being driven by the increasing usage of single-use bioreactors for mammalian cell culture in several research studies is other key factor expected to drive the market growth significantly in the coming years
- By molecule type insights, the vaccines segment held a larger share in 2021. This is due to the less expensive and is also available in smaller volumes. Thus, allowing manufacturers to test different cell lines as well as growth conditions more quickly and at a lower cost to improve vaccine manufacturing
- By application insights, the research and development (R&D)/process development segment held a larger share in 2021. Single-use bioreactors are most commonly used in (GMP) production, process development, and research. Furthermore, the growing adoption of single-use bioreactors in process development is facilitating the market growth
- By usage insights, the lab-scape production segment held a larger share in 2021. The various types of waste creation and bioreactor operation be included in controlled laboratory-scale studies before scaling up. Due to such advantages offered by lab-scalee bioreactors, the market is expected to grow during the forecast period
- By end-use insights, the CMOs & CROs segment held a larger share in 2021. CMOs have constantly changing processing facilities as well as lines, and the more stable product developers for bioprocessing equipment & facilities. Thus, propelling the market growth
Key Topics Covered:
Chapter 1 Methodology And Scope
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends, & Scope
Chapter 4 Competitive Landscape
Chapter 5 Single – Use Bioreactors Market: Product Business Analysis
Chapter 6 Single – Use Bioreactors Market: Type Business Analysis
Chapter 7 Single – Use Bioreactors Market: Type Of Cell Business Analysis
Chapter 8 Single – Use Bioreactors Market: Molecule Type Business Analysis
Chapter 9 Single – Use Bioreactors Market: Application Business Analysis
Chapter 10 Single – Use Bioreactors Market: Usage Type Business Analysis
Chapter 11 Single – Use Bioreactors Market: End – Use Business Analysis
Chapter 12 Single – Use Bioreactors Market: Regional Business Analysis
Chapter 13 Company Profiles
Companies Mentioned
- Abec, Inc.
- Able Corporation & Biott Corporation
- Bbi – Biotech GmbH
- Cellexus
- Celltainer Biotech Bv
- Danaher
- Distek Inc.
- Eppendorf AG
- G&G Technologies, Inc.
- Getinge Ab
- Merck Kgaa
- Sigma – Aldrich Co. LLC
- Satake Chemical Equipment Mfg. Ltd.
- Pbs Biotech, Inc.
- Sartorius AG
- Solida Biotech GmbH
- Stobbe Pharma GmbH
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/wrla7h
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900